The findings highlight the potential benefits of newer biologics targeting IL-12, IL-23, and IL-17 while also raising ...

Overall, the study’s findings support the use of Amjevita and Imraldi as equally effective alternatives to Humira in the real ...

IL-23, or IL-17 reduced serious infections, while tofacitinib increased infection risk, according to one study.

Risankizumab was associated with more significant improvements among patients with plaque psoriasis when compared with other biologic therapies.

Join Drs Steven Feldman and Robert Kushner as they discuss the role of dermatologists in treating obesity in conjunction with psoriasis.

When psoriasis develops on your feet, it can cause uncomfortable itching or soreness that makes tasks like walking difficult. Psoriasis, an autoimmune skin condition, usually causes scaly rashes ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Until about ...

Psoriasis and psoriatic arthritis (PsA) are both psoriatic diseases, which means they are related. Psoriasis increases your risk of PsA, but this doesn't mean you will get it. While there's no ...

BRIDGEWATER, N.J., and BENGALURU, India, March 7, 2025 /PRNewswire/ -- Biocon Biologics Ltd. (BBL), a fully integrated global biosimilars company and subsidiary of Biocon Ltd. (BSE code: 532523 ...

A recent review highlights how the Mediterranean diet can reduce inflammation and improve outcomes for chronic skin ...